Contrast-enhanced ultrasonography-CT/MRI fusion guidance for percutaneous ablation of inconspicuous, small liver tumors: improving feasibility and therapeutic outcome.

Publication Year: 2024

DOI:
10.1186/s40644-023-00650-y

PMCID:
PMC10762814

PMID:
38172949

Journal Information

Full Title: Cancer Imaging

Abbreviation: Cancer Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Diagnostic Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe institutional review board approved this prospective study (IRB No 1811-136-989). Written informed consent was obtained prior to enrollment from all patients in this study. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

Evidence found in paper:

"Funding Financial support was provided by Canon Medical (No. 0620101950) and Siemens Healthineers (No. 0620200760)."

Evidence found in paper:

"Trial registration ClinicalTrials.gov, NCT05445973. Registered 17 June 2022 – Retrospectively registered, http://clinicaltrials.gov/study/NCT05445973?id=NCT05445973&rank=1."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025